Dr. István Nagy has a PhD in Molecular Immunology (Univ. of Szeged, Hungary) and a MSc in Molecular Biology (Univ. of Pécs, Hungary). He spent 3 years as a post-doctoral fellow at the Institute of Genetics and Molecular and Cellular Biology (IGBMC, Strasbourg, France) studying the epigenetic control of cell fate determination before returning to Hungary (BAYGEN Institute, Szeged). His main research topic is the innate immune system of the skin, focusing on the intimate relationship of commensal microorganisms and the host cells. He utilizes the power of next-generation sequencing in order to identify mutations accounting for pathogeneticity and antibiotic resistance occurring in skin commensals.
Apart of his research group, Dr. Nagy is heading the Next-Generation Sequencing Platform of the BAYGEN Institute, which operates with two next-generation sequencing instruments (SOLiD 4 and 5500xl SOLiD System). He is also a co-founder of the privately owned biotechnology company SeqOmics Ltd. which operates, among others, an Ion Torrent PGM instrument.
Application of Next Generation Sequencing technology to gene expression studies. Are we there yet?
as author at Predavanja na Nacionalnem inštitutu za biologijo, Ljubljana,